Registration
BGR GOVERNMENT AFFAIRS for ROIVANT SCIENCES, INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advise client on legislative and administrative policy-making related to the biopharmaceutical industry generally, and client priorities specifically. Includes raising awareness amongst public officials about the importance of addressing disease areas of high unmet medical need where client and its affiliates are working to develop new medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER New | Sp Asst Pres LA; Asst Com Leg, FDA; Sp Asst Sec HHS; Con Asst; Off of WH Liaison DoD;Con Asst, Off of Sec Lab |
| BRENT ALAN DEL MONTE New | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee |
| RYAN LONG New | Prof. Stf, Csel, & Chief Csel H E&C Cmte, LC Rep Norwood; LA& LD Rep Barton |
| ROBB WALTON New | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| AXOVANT SCIENCES GMBH | Switzerland | Switzerland | — | — |
| ROIVANT SCIENCES GMBH | Switzerland | Switzerland | — | — |
| ROIVANT SCIENCES HOLDINGS LTD. | United Kingdom | United Kingdom | 100.0% | — |
| ROIVANT SCIENCES LTD. | Bermuda | Bermuda | 100.0% | — |
| AXOVANT SCIENCES LTD. | Bermuda | Bermuda | — | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.